Scholarships for Outreach Workers and Health Educators to APHA

TRAVEL SCHOLARSHIPS FOR COMMUNITY-BASED PROFESSIONALS ATTENDING APHA CONFERENCE

The Community-Based Public Health Caucus (CBPH) of the American Public Health Association (APHA) is offering financial support for attendees of the APHA Annual Meeting, to be held in Boston November 4-8, 2006. Funding is available to support the travel of representatives from community-based health organizations, and applications must be received by July 17 to be considered. Priority will be given to those community-based organization members who are active in the CBPH Caucus or who will be presenting at their sponsored sessions. For more information on these travel scholarships, go to http://www.cbphcaucus.org.

Deadline passed; contact information removed, 07/20/07.

Funding Opportunity: RWJF Caring Across Communities Call for Proposal

Caring Across Communities
Addressing Mental Health Needs of Diverse Children and Youth

Application Deadline: July 28, 2006
Interest Area: Vulnerable Populations

Purpose: Caring Across Communities, a Robert Wood Johnson Foundation (RWJF) initiative, will address the mental health needs of underserved children and youth by supporting school-connected mental health services for students who require them. Special emphasis will be given to projects that help children of immigrant and refugee families overcome the cultural and language barriers to mental health services.

Click here for more information.

Deadline passed; link removed, 07/20/07.

Urgent – Voluntary Drug Recall: Triphasil - 28 Tablets

Wyeth Pharmaceuticals is voluntarily recalling several lots of Triphasal-28 (levonorgestrel and ethinyl estradiol tablets) triphasic regimen, because of issues with laboratory investigations and notifications pertaining to the presence of a packaging extractable.

For further details on the specific recalled lots number please see this letter from Wyeth. (PDF, 64.1K)

Medroxyprogesterone (generic Depo-Provera) ON SALE for the month of June!

TEVA Pharmaceuticals is having a special promotion for FPCPP members. Medroyxyprogesterone (generic Depo-Provera) syringe is being offered at $8.68. Members can purchase this product through our wholesaler R&S Northeast, LLC at (800) 976-7741.

You have to be a Title X recipient and a member of the FPCPP Cooperative to qualify for this promotional offer.

CFHC Title X Fiscal Workshop Series 1: Cost Allocation Methodologies Nuts and Bolts

CFHC is pleased to announce that our Finance Department is offering the following free workshop for  Delegate Agency Fiscal staff.   

Date: Thursday, June 29, 2006

Time: 10:00 a.m. – 2:00 p.m. (lunch will be provided)

Location: Radisson Wilshire Plaza Hotel, 3515 Wilshire Blvd., Los Angeles, CA 90010
Location Phone: (213) 381-7411

CFHC’s Cost Allocation Methodologies Nuts and Bolts workshop  will be an extensive overview of  the various allocation methods for allocating direct and indirect cost for your Title X grant.  The training will include development, implementation, and monitoring methodologies with guidance from OMB circulars, Generally Accepted Accounting Principles and Practices and Title X regulations.

CFHC encourages Delegate Agencies to send fiscal staff only to this workshop.  These individuals should be the staff that are responsible for your agency’s SRERs, accounting functions, and budget functions. 

Please complete the registration form and return to Ted Williams, Facility Coordinator, by by Monday, June 26, 2006.

We look forward to seeing you in there!

Event passed; link to registration form removed, 07/20/07.

Survey on CHT Practicum Topics

We are pleased to announce that The Center for Health Training (CHT) has Title X funding for a limited number of clinical practicums. The practicum can range from examination skills to IUD insertions.  The California Family Health Council Inc. is working with CHT to identify the number of health care providers who would be interested in attending and areas(s) of greatest need.

Please assist us with this endeavor by completing our two-question survey (in MSWord format) and emailing it to kass-anneseb@cfhc.org by June 16, 2006.

Deadline passed; link to survey removed 07/20/07.

New Extended Cycle Oral Contraceptive

Barr Laboratories on Thursday announced it has received approval from FDA for its extended-cycle oral contraceptive Seasonique, according to spokesperson Susan Cruzan, the AP/New Bedford Standard Times reports (AP/New Bedford Standard Times, 5/25).  Seasonique is similar to Barr's Seasonale, which was approved in September 2003, and allows users to reduce their number of annual menstrual periods from 13 to four.  Unlike Seasonale, with which women take 84 active pills consecutively and then take seven placebo pills, Seasonique uses pills containing a 0.01 milligram dose of estrogen in place of the placebo pills (Kaiser Daily Women's Health Policy Report, 4/7).  Barr has said that using the low-dose estrogen pills instead of the placebo pills for seven days limits bloating, hormonal fluctuations and breakthrough bleeding, the Standard Times reports.

Seasonique is expected to be available for prescription sales in July and is projected to cost about one dollar per pill (AP/New Bedford Standard Times, 5/25).

Access this story and related links online.